What's Happening?
The Royal Pharmaceutical Society (RPS) has joined forces with other health organizations to call for a more integrated approach to contraceptive commissioning in England. This initiative is in response to a statement from the Advisory Group on Contraception
(AGC), which highlights the fragmentation in the NHS that has particularly underserved women, especially in the area of contraception. The AGC, supported by groups like the Royal College of Obstetricians and Gynaecologists, points out that the current system, which splits responsibility between the NHS and local authorities, leads to regional disparities in access to contraception. This fragmentation results in confusion, varied access to preferred contraceptive options, and long waiting lists for gynecological services. The AGC advocates for a collaborative, pathway-based approach that aligns with women's needs throughout their lives, aiming to reduce health inequalities and improve outcomes.
Why It's Important?
The call for improved contraceptive commissioning is significant as it addresses systemic health inequalities faced by women due to fragmented healthcare services. By advocating for a more integrated approach, the RPS and AGC aim to empower women with informed choices and better health outcomes. This initiative could lead to more consistent access to contraception, reducing unintended pregnancies and easing the burden on healthcare services like GP practices and sexual health clinics. The move towards a 'neighbourhood health service' as part of the NHS's ten-year health plan could transform how women's health services are delivered, ensuring that women's health is prioritized and not overlooked.
What's Next?
The AGC has called for the Department of Health and Social Care to issue clear guidelines for collaborative commissioning of contraception and to incentivize national collaboration. This could lead to the establishment of a women's health champion in every integrated care system, ensuring oversight and accountability. The implementation of the NHS's ten-year health plan, which emphasizes prevention-first care, offers an opportunity to embed integrated contraceptive pathways. Pharmacies, like the Green Lane Pharmacy in Liverpool, which piloted an NHS contraceptive implant service, could play a crucial role in expanding access to contraception and reducing health inequalities.
